Rezultati

eNauka >  Results >  Adalimumab Safety in Inflammatory Bowel Disease: A Clinical Cohort Study with Time-to-Event Analysis and FAERS Signal Assessment
Title: Adalimumab Safety in Inflammatory Bowel Disease: A Clinical Cohort Study with Time-to-Event Analysis and FAERS Signal Assessment
Authors: Milašinović, Bojana; Marković, Srđan  ; Vezmar-Kovačević, Sandra  ; Svorcan, Petar  ; Miljković, Branislava  ; Vučićević, Katarina  
Issue Date: 2026
Publication: Pharmaceuticals
ISSN: 1424-8247 Pharmaceuticals Search Idenfier
Publisher: Basel, Switzerland : MDPI
Type: Article
Collation: vol. 19 br. 8 str. 1239
DOI: 10.3390/ph19081239
WoS-ID: 001858881300001
PMID: 42653736
PMCID: PMC13516148
URI: https://farfar.pharmacy.bg.ac.rs/handle/123456789/6552
https://enauka.gov.rs/handle/123456789/1050274
URL: https://www.mdpi.com/1424-8247/19/8/1239
Project: optYmAb - Improving Clinical Outcomes with Precision Dosing in Patients with Inflammatory Bowel Disease Through Investigating Variability of Monoclonal Antibodies Based on Population Pharmacokinetic-Pharmacodynamic Modeling
M-category: 
21aM21a

Alt metrika
Dimensions
Unpaywall

Creative Commons licenca